INCUBASE Studio Brings Unmissable Anime Experiences Across Asia: From Crayon Shinchan to Beloved BL Hits
HONG KONG, June 3, 2025 /PRNewswire/ -- INCUBASE Studio is bringing anime to life across Asia with a wave of...
Read moreLatest Post
Connect to Care Global Launches to Drive Post-Aid Development Across Global South
Singapore-based consultancy offers political, digital, business-driven and South–South solutions to overcome reduction in Global North aid budgets. SINGAPORE, June 3,...
Read moreLocal stocks open up more than 0.5pc
The Hang Seng Index rose 123 points, or 0.53 percent, to open at 23,281 points on Tuesday. Mainland stocks opened...
Read more
Translators’ Voices: China shares technological achievements with the world for mutual benefit
BEIJING, June 3, 2025 /PRNewswire/ -- May 30, 2025 marks the ninth National Science and Technology Workers Day. In the early...
Read more
welzo Establishes New Subsidiary in Singapore to Accelerate Expansion into Southeast Asia
FUKUOKA, Japan, June 3, 2025 /PRNewswire/ -- welzo Inc., an innovation-driven company in the agri-horticultural sector (Head Office: Hakata-ku, Fukuoka...
Read more
XellSmart Secures FDA Clearance for Three Phase I INDs of Allogeneic iPSC-Derived Cell Therapies Targeting Major CNS Diseases: Parkinson’s Diseases, Spinal Cord Injury and ALS
SUZHOU, China, June 3, 2025 /PRNewswire/ -- XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the...
Read more
Jenscare released 30-day follow-up results of LuX-Valve Plus TRINITY study and 1-year follow-up results of JensClip TMVr at EuroPCR 2025
BEIJING, June 3, 2025 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device...
Read more
2025 ASCO Presentation: Innovent Biologics Announces Updated Data of IBI354 (Novel anti-HER2 ADC) From the Phase 1/2 Clinical Study in Advanced Ovarian Cancer, Breast Cancer and Other Solid Tumors
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops,...
Read moreASCO 2025 Oral Presentation: Innovent Biologics Announces Updated Data of IBI343 (Novel Anti-CLDN18.2 ADC) From the Phase 1 Clinical Study in Patients with Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, June 3, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
Read more
2025 ASCO ｜Oral Presentation: Disitamab Vedotin Achieves Stellar Efficacy as First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Gastric Cancer
YANTAI, China, June 3, 2025 /PRNewswire/ -- On June 2 (Chicago time), in an oral presentation at the 2025 ASCO...
Read more
Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.
📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com